Literature DB >> 20635895

Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation.

Alexander J Muller, Laura Mandik-Nayak, George C Prendergast.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20635895      PMCID： PMC4096238          DOI： 10.2217/imt.10.22

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  29 in total

1.  Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

Authors:  A L Mellor; J Sivakumar; P Chandler; K Smith; H Molina; D Mao; D H Munn
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

2.  Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.

Authors:  Alexander J Muller; James B DuHadaway; Daniel Jaller; Peter Curtis; Richard Metz; George C Prendergast
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

3.  Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis.

Authors:  Runkuan Yang; Takashi Uchiyama; Sean M Alber; Xiaonan Han; Simon K Watkins; Russell L Delude; Mitchell P Fink
Journal:  Crit Care Med       Date:  2004-07       Impact factor: 7.598

4.  The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity.

Authors:  Grant N Scott; James DuHadaway; Elizabeth Pigott; Natalie Ridge; George C Prendergast; Alexander J Muller; Laura Mandik-Nayak
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

5.  Cancer. Addiction to oncogenes--the Achilles heal of cancer.

Authors:  I Bernard Weinstein
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

6.  Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific.

Authors:  Babak Baban; Phillip Chandler; Doris McCool; Brendan Marshall; David H Munn; Andrew L Mellor
Journal:  J Reprod Immunol       Date:  2004-04       Impact factor: 4.054

Review 7.  The immunobiology of cancer immunosurveillance and immunoediting.

Authors:  Gavin P Dunn; Lloyd J Old; Robert D Schreiber
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

8.  Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion.

Authors:  Takashi Uchiyama; Russell L Delude; Mitchell P Fink
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440

9.  Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock.

Authors:  Runkuan Yang; David J Gallo; Jeffrey J Baust; Takashi Uchiyama; Simon K Watkins; Russell L Delude; Mitchell P Fink
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-07       Impact factor: 4.052

10.  Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice.

Authors:  Runkuan Yang; Xiaonan Han; Russell L Delude; Mitchell P Fink
Journal:  J Lab Clin Med       Date:  2003-11
View more
  12 in total

1.  IDO is a nodal pathogenic driver of lung cancer and metastasis development.

Authors:  Courtney Smith; Mee Young Chang; Katherine H Parker; Daniel W Beury; James B DuHadaway; Hollie E Flick; Janette Boulden; Erika Sutanto-Ward; Alejandro Peralta Soler; Lisa D Laury-Kleintop; Laura Mandik-Nayak; Richard Metz; Suzanne Ostrand-Rosenberg; George C Prendergast; Alexander J Muller
Journal:  Cancer Discov       Date:  2012-07-19       Impact factor: 39.397

2.  Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase.

Authors:  Mee Young Chang; Courtney Smith; James B DuHadaway; Jennifer R Pyle; Janette Boulden; Alejandro Peralta Soler; Alexander J Muller; Lisa D Laury-Kleintop; George C Prendergast
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

Review 3.  The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.

Authors:  Sunil Thomas; Jacques Izard; Emily Walsh; Kristen Batich; Pakawat Chongsathidkiet; Gerard Clarke; David A Sela; Alexander J Muller; James M Mullin; Korin Albert; John P Gilligan; Katherine DiGuilio; Rima Dilbarova; Walker Alexander; George C Prendergast
Journal:  Cancer Res       Date:  2017-03-14       Impact factor: 12.701

4.  Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis.

Authors:  Lauren M F Merlo; Samantha Grabler; James B DuHadaway; Elizabeth Pigott; Kaylend Manley; George C Prendergast; Lisa D Laury-Kleintop; Laura Mandik-Nayak
Journal:  Clin Immunol       Date:  2017-02-20       Impact factor: 3.969

5.  Cancer: Why tumours eat tryptophan.

Authors:  George C Prendergast
Journal:  Nature       Date:  2011-10-12       Impact factor: 49.962

6.  In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1.

Authors:  Ian M Zitron; David O Kamson; Sam Kiousis; Csaba Juhász; Sandeep Mittal
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

Review 7.  Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer.

Authors:  George C Prendergast; William J Malachowski; Arpita Mondal; Peggy Scherle; Alexander J Muller
Journal:  Int Rev Cell Mol Biol       Date:  2017-09-21       Impact factor: 6.813

Review 8.  Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond.

Authors:  Alexander J Muller; Mark G Manfredi; Yousef Zakharia; George C Prendergast
Journal:  Semin Immunopathol       Date:  2018-09-10       Impact factor: 9.623

9.  Systemic treatment with CpG-B after sublethal rickettsial infection induces mouse death through indoleamine 2,3-dioxygenase (IDO).

Authors:  Lijun Xin; Thomas R Shelite; Bin Gong; Nicole L Mendell; Lynn Soong; Rong Fang; David H Walker
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

10.  Indoleamine 2,3-Dioxygenase Is Dispensable for The Immunomodulatory Function of Stem Cells from Human Exfoliated Deciduous Teeth.

Authors:  Razieh Alipour; Masoumeh Masoumi Karimi; Batool Hashemi-Beni; Minoo Adib; Nasrin Sereshki; Farzaneh Sadeghi
Journal:  Cell J       Date:  2016-09-26       Impact factor: 2.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.